The OmniAb exploration platform offers Ligand’s partners in the pharmaceutical sector the opportunity to access a wide range of antibody repertoires and advanced screening technologies to support the discovery of cutting-edge therapeutics. At the core of the OmniAb platform lies the Biological Intelligence™ (BI) of our unique transgenic animals, such as OmniRat, OmniChicken, and OmniMouse, which have been genetically engineered to produce antibodies containing human sequences, thus facilitating the development of human therapeutic candidates.
OmniAb
Headquarters
United States of America